Position in RZLT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,771,408
+$1,841,305 QoQ
Shares Held
725,271
+14.6% QoQ
Ownership
0.753%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 144 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. RZLT ranks #188 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in RZLT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,771,408 | 725,271 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,930,103 | 632,821 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,740,062 | 737,315 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,261,067 | 772,454 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,639,637 | 591,847 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $300,950 | 103,776 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $465,308 | 94,961 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $470,241 | 96,957 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $288,882 | 67,182 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $171,426 | 67,226 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $83,397 | 83,986 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $113,399 | 85,909 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $170,315 | 86,018 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $143,613 | 74,799 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $178,114 | 86,046 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $236,778 | 86,416 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $274,863 | 85,097 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $174,123 | 51,516 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $249,960 | 52,293 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $268,488 | 35,899 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $458,409 | 32,124 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||